The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| SCLP | -32.2% | -33.29% | -7.78% | +227% |
| S&P | +16.9% | +95.99% | +14.39% | +632% |
Scancell Holdings Plc engages in the development of novel therapeutic vaccines for the treatment of cancer. Its vaccine platform includes Moditope and ImmunoBody. The company was founded by Lindy Gillian Durrant in 1997 and is headquartered in Oxford, the United Kingdom.
Scancell Holdings Plc (LON:SCLP) encouraged by "clinical benefit" from new vaccine.
Royal Dutch Shell, AstraZeneca, and Scancell Holdings all dip on mixed news.
Currently no data to display
Currently no data to display.
Currently no data to display.
| Metric | YoY Change |
|---|
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
